Successful treatment of thrombocytopenia due to marrow metastases of breast cancer with weekly docetaxel [4]

Journal of the National Cancer Institute

Volumn 95, Issue 11, 2003, Pages 831-832

  Ballot, Josephine ^a   McDonnell, Deirdre ^a   Crown, John ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CAPECITABINE; DOCETAXEL; PAMIDRONIC ACID; TAMOXIFEN; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; PACLITAXEL; TAXOID;

BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE MARROW SUPPRESSION; BONE METASTASIS; BREAST CANCER; HUMAN; LETTER; NEUTROPENIA; PRIORITY JOURNAL; SPINE METASTASIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; BONE MARROW CANCER; BREAST TUMOR; CASE REPORT; DRUG ADMINISTRATION; FEMALE; METASTASIS; MIDDLE AGED; PATHOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; TAXOIDS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0038042070     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.11.831-a     Document Type: Letter

References (7)

1. Wong KF, Chan JK, Ma SK. Solid tumour with initial presentation in the bone marrow-a clinicopathologic study of 25 adult cases. Hematol Oncol 1993;11:35-42.
2. Sugarbaker PH, Skarin AT, Wilson RE. Thrombocytopenia from metastatic carcinoma of the breast. Effective managements of patients with this complication. Arch Surg 1973; 107:523-7.
3. Rodriguez-Kraul R, Hortobagyi GN, Buzdar AU, Blumenschein GR. Combination chemotherapy for breast carcinoma metastatic to bone marrow. Cancer 1981;48:227-32.
4. Ingle JN, Tormey DC, Bull JM, Simon RM. Bone marrow involvement in breast cancer: effect on response and tolerance to combination chemotherapy. Cancer 1977;39:104-11.
5. Dady PJ, Gazet JC, Ford HT, Powles TJ. Combination chemotherapy for thrombocytopenia with bone marrow metastases from breast cancer. Br Med J 1977;1:554.
6. Hainsworth JD, Burris HA 3rd, Erland JB, Thomas M, Greco FA. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer. J Clin Oncol 1998;16:2164-8.
7. Elting LS, Cantor SB, Martin CG, Hamblin L, Kurtin D, Rivera E, et al. Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors. Cancer 2003;97:1541-50.